Oregovomab

By Evans H.C.   Perry C.M.  

American Journal of Cancer, Vol. 2, Iss. 2, 2003-01 ,pp. : 125-133

Adis International

Access to resources Recommend Favorite

Mitotic Catastrophe in Malignant Epithelial Tumors: The Pathologist’’s Viewpoint

By Caruso Rosario   Fedele Francesco   Lucianòò Roberta   Branca Giovanni   Parisi Claudia   Paparo Domenica   Parisi Antonino  

Ultrastructural Pathology, Vol. 35, Iss. 2, 2011-04 ,pp. : 66-71

Informa Healthcare

Access to resources Recommend Favorite

Randomized, placebo-controlled study of oregovomab for consolidation of clinical remission in patients with advanced ovarian cancer

By Thompson Patricia   Daud Adil   Lee H  

The Women's Oncology Review, Vol. 5, Iss. 3, 2005-09 ,pp. : 169-171

Informa Healthcare

Access to resources Recommend Favorite

Capecitabine: A Viewpoint by Werner Scheithauer

By Scheithauer Werner  

American Journal of Cancer, Vol. 4, Iss. 5, 2005-01 ,pp. : 324-325

Adis International

Access to resources Recommend Favorite

Bevacizumab: A Viewpoint by Richard M. Goldberg

By Goldberg Richard M.  

American Journal of Cancer, Vol. 3, Iss. 3, 2004-01 ,pp. : 195-196

Adis International

Access to resources Recommend Favorite